Trial intelligence / Profile preview

L-PRF in Periodontitis

NCT04978324Phase 3Withdrawn

Sponsor
Virginia Commonwealth University
Start
May 2022
Primary completion
Dec 2022
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of Platelet-Rich Fibrin in chronic periodontitis, sponsored by Virginia Commonwealth University. Planned start May 2022; status: withdrawn.

02

Drugs

Platelet-Rich Fibrin
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on NCT04978324.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04978324.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call